AL
AVEO

Airain Ltd’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Airain Ltd’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,789
Closed -$20K – 999
2014
Q3 		$20K Buy
+1,789
New +$22.7K ﹤0.01% 766
2013
Q4 		– Sell
-1,922
Closed -$40K – 750
2013
Q3 		$40K Sell
1,922
-507
-21% -$11.6K 0.01% 451
2013
Q2 		$61K Buy
+2,429
New +$104K 0.01% 528

Other funds holding AVEO

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DVC
Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GX
Greylock XI Cambridge, Massachusetts $7.71M AUM 28.23% 1-Year Est. Return

Airain Ltd's AVEO Position: Q4 2014 in Review

Airain Ltd sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2014, closing a stake of 1,789 shares — an estimated $20K sold.

Airain Ltd first reported a position in AVEO in Q2 2013 and held it in 3 quarters. The position peaked at $61K in Q2 2013. 51 funds tracked by Wall St. Rank hold AVEO as of Q4 2014.

  • Airain Ltd reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • Airain Ltd sold 1,789 AVEO Pharmaceuticals, Inc. shares in Q4 2014, an estimated $20K.
  • Airain Ltd first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 3 quarters.
  • Airain Ltd's AVEO Pharmaceuticals, Inc. position peaked at $61K in Q2 2013.
  • 51 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2014.

Based on Airain Ltd's 13F filing for Q4 2014, filed 12 Feb 2015.